A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants

Clinical Pharmacology in Drug Development
Ridhi ParasrampuriaParul Patel

Abstract

This study investigates the impact of severe renal impairment on the pharmacokinetics of cabotegravir, an investigational HIV-1 integrase inhibitor. This was a phase I, open-label, parallel-group, multicenter study conducted in 8 participants with severe renal impairment (creatinine clearance <30 mL/min; no renal replacement therapy) and 8 healthy participants (creatinine clearance >90 mL/min; 2 women/group; 6 men/group) matched for sex, age (±10 years), and body mass index (±25%). Participants received a single 30-mg oral cabotegravir tablet to determine total and unbound plasma cabotegravir concentrations. Arithmetic and geometric least squares means were calculated, and cabotegravir noncompartmental pharmacokinetic parameters were compared using geometric least squares mean ratios with 90% confidence intervals. Safety was assessed throughout the study. Geometric least squares mean ratios (90% confidence intervals) were 0.97 (0.84-1.14) for area under the plasma concentration-time curve extrapolated to infinity, 1.01 (0.87-1.17) for maximum observed plasma concentration, 1.31 (0.84-2.03) for unbound cabotegravir 2 hours after dosing, and 1.51 (1.19-1.92) for unbound cabotegravir 24 hours after dosing. All adverse events were ...Continue Reading

References

Apr 8, 2003·Current Drug Metabolism·Vincent Pichette, François A Leblond
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samir K GuptaLynda A Szczech
Aug 6, 2008·Expert Opinion on Drug Metabolism & Toxicology·Albert W Dreisbach, Juan J L Lertora
Oct 25, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan WinstonBenjamin Young
Mar 16, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·James J KohlerWilliam Lewis
Nov 17, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sebastian KlammtSteffen Mitzner
Dec 31, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vasantha JotwaniMichael G Shlipak
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·Susan L FordStephen Piscitelli
Oct 8, 2013·European Journal of Clinical Pharmacology·Stephen WellerStephen C Piscitelli
Oct 9, 2013·Current Opinion in HIV and AIDS·William R SpreenJohn C Pottage
Nov 15, 2013·Current Opinion in HIV and AIDS·Lene RyomJens D Lundgren
Aug 21, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·William SpreenStephen Piscitelli
Aug 27, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amy L CorneliUNKNOWN FEM-PrEP Study Group
Mar 1, 2015·Clinical Nephrology·Saraladevi NaickerJeffrey B Kopp
Jun 8, 2015·Current Opinion in HIV and AIDS·David A Margolis, Marta Boffito
Jul 3, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Gary David BowersWilliam R Spreen
Jul 26, 2017·Antimicrobial Agents and Chemotherapy·S L FordW Spreen
Sep 20, 2018·Clinical Pharmacology in Drug Development·Parul PatelWilliam Spreen

❮ Previous
Next ❯

Citations

Jun 9, 2019·The Journal of Pharmacology and Experimental Therapeutics·Mitesh PatelMaciej J Zamek-Gliszczynski
Oct 24, 2019·Current Opinion in HIV and AIDS·Meredith E ClementRaphael J Landovitz
Apr 7, 2020·Expert Opinion on Drug Metabolism & Toxicology·Jenna L Yager, Peter L Anderson
Nov 26, 2019·Current Opinion in HIV and AIDS·Ronald D'Amico, David A Margolis
May 29, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dhanashree H Surve, Anil B Jindal

❮ Previous
Next ❯

Methods Mentioned

BETA
equilibrium dialysis

Clinical Trials Mentioned

NCT02354937

Software Mentioned

STAT
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.